Fredun Pharmaceuticals (BOM:539730) E10: ₹23.90 (As of Mar. 2026)


BOM:539730 Fredun Pharmaceuticals Ltd BOM:539730
67 GF Score
Price ₹2,588.80
GF Value ₹1,582.95
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Fredun Pharmaceuticals E10?

Fredun Pharmaceuticals BOM:539730 -6.16% 67 E10 is ₹23.90 as of Mar. 2026. GuruFocus rates BOM:539730 with a GF Score™ of 67/100 and a GF Value™ of ₹1,582.95 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Fredun Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹18.220. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹23.90 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 37.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Fredun Pharmaceuticals was 37.80% per year. The lowest was 37.80% per year. And the median was 37.80% per year.

As of today (2026-07-04), Fredun Pharmaceuticals's current stock price is ₹2588.80. Fredun Pharmaceuticals's E10 for the quarter that ended in Mar. 2026 was ₹23.90. Fredun Pharmaceuticals's Shiller PE Ratio of today is 108.32.

During the past 13 years, the highest Shiller PE Ratio of Fredun Pharmaceuticals was 182.80. The lowest was 42.02. And the median was 84.27.


Fredun Pharmaceuticals  (BOM:539730) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Fredun Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2588.80/23.90
=108.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Fredun Pharmaceuticals was 182.80. The lowest was 42.02. And the median was 84.27.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Fredun Pharmaceuticals E10 Related Terms


Fredun Pharmaceuticals E10 Historical Data

* Premium members only.

The historical data trend for Fredun Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fredun Pharmaceuticals E10 Chart

Fredun Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.43 9.13 12.70 0.00 23.90

Fredun Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 17.65 19.96 22.17 23.90

BOM:539730 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fredun Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fredun Pharmaceuticals Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fredun Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fredun Pharmaceuticals's Shiller PE Ratio falls into.


BOM:539730
67GF Score
Fredun Pharmaceuticals Ltd BOM:539730
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fredun Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fredun Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=18.22/164.2724*164.2724
=18.220

Current CPI (Mar. 2026) = 164.2724.

Fredun Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201606 2.560 105.961 3.969
201609 1.394 105.961 2.161
201612 0.590 105.196 0.921
201703 1.820 105.196 2.842
201706 1.560 107.109 2.393
201709 1.470 109.021 2.215
201712 0.690 109.404 1.036
201803 2.130 109.786 3.187
201806 -1.838 111.317 -2.712
201809 5.640 115.142 8.047
201812 4.280 115.142 6.106
201903 3.210 118.202 4.461
201906 0.590 120.880 0.802
201909 2.200 123.175 2.934
201912 2.550 126.235 3.318
202003 -0.570 124.705 -0.751
202006 0.090 127.000 0.116
202009 2.070 130.118 2.613
202012 3.350 130.889 4.204
202103 -0.460 131.771 -0.573
202106 0.820 134.084 1.005
202109 4.610 135.847 5.575
202112 4.220 138.161 5.018
202203 5.130 138.822 6.070
202206 2.120 142.347 2.447
202209 7.110 144.661 8.074
202212 7.660 145.763 8.633
202303 6.200 146.865 6.935
202306 5.240 150.280 5.728
202309 8.400 151.492 9.109
202312 9.050 152.924 9.722
202403 10.773 153.035 11.564
202406 8.790 155.789 9.269
202409 9.050 157.882 9.416
202412 11.290 158.323 11.714
202503 0.000 157.552 0.000
202506 14.330 159.755 14.735
202509 19.980 162.289 20.224
202512 22.190 163.281 22.325
202603 18.220 164.272 18.220

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹23.90 mean?
Fredun Pharmaceuticals (BOM:539730) has a E10 of ₹23.90 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Fredun Pharmaceuticals and its competitors.
Is Fredun Pharmaceuticals' E10 too high?
Fredun Pharmaceuticals' current E10 is ₹23.90. Overall, Fredun Pharmaceuticals has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fredun Pharmaceuticals' E10 compare to ZTS and UTHR?
Fredun Pharmaceuticals' E10 of ₹23.90 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Fredun Pharmaceuticals and its competitors. Fredun Pharmaceuticals's current E10 is ₹23.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fredun Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Fredun Pharmaceuticals (BOM:539730) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,582.95, compared to a current price of ₹2,588.80 — trading 63.5% above its estimated fair value. The current E10 is ₹23.90. Fredun Pharmaceuticals' overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Fredun Pharmaceuticals (BOM:539730), the current E10 is ₹23.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fredun Pharmaceuticals (BOM:539730) Overvalued in 2026?

Based on GuruFocus' analysis, Fredun Pharmaceuticals stock appears to be overvalued. The current stock price of ₹2,588.80 is trading 63.5% above its estimated GF Value™ of ₹1,582.95. GuruFocus considers Fredun Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for BOM:539730:

  • E10: ₹23.90
  • GF Value™: ₹1,582.95 vs. price of ₹2,588.80 (63.5% above fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the BOM:539730 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fredun Pharmaceuticals Business Description

Address Ganpatrao Kadam Marg, Delisle Road, 11th Floor, Urmi Estate 95, Lower Parel (West), Mumbai, MH, IND, 400013
Fredun Pharmaceuticals Ltd in its Endeavour to move ahead has now ventured into manufacturing of dietary /herbal supplements, nutraceuticals, and other healthcare products along with Animal Healthcare products also with products ranging from allopathic formulations to on field diagnostic kits, Company's main objective is to be a holistic healthcare provider. The group is dedicated to improving lives of people. The Company operates only in a single segment i.e. Pharmaceutical Segment. The company has presence in Domestic as well as International market. The company generates majority of revenue from Domestic market.
67GF Score

Get the complete analysis for BOM:539730

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,588.80
Price
₹1,582.95
GF Value